Search - tctmd.com

Displaying 41 - 58 of 58

Sort: Relevancy | Date

Presentation TCTAP 2012

From ABSORB Cohort A to ABSORB III and IV Randomized Trials

Presenter: Stephen G. Ellis

April 26, 2012

Presentation TCTAP 2012

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Presenter: Gregg W. Stone

April 26, 2012

Presentation TCTAP 2012

Everolimus-Eluting Stent Implantation for Unprotected Left Main Stenosis:

Presenter: Young-Hak Kim

April 26, 2012

Presentation TCTAP 2012

Drug-Eluting Stent In Lower Extremity Intervention: Changed Landscape in the Current Practice?

Presenter: Mark W. Burket

April 26, 2012

Presentation TCTAP 2012

CROSS and PERFECT Trials: Preliminary Results

Presenter: Young-Hak Kim

April 26, 2012

Presentation TCTAP 2012

ACCEL-LOADING-ACS: Multicenter Randomized Trial Evaluating Efficacy of Cilostazol on Platelet aggregation, Inflammation, and Myonecrosis in ACS Patients

Presenter: Young-Hoon Jeong

April 26, 2012

Presentation TCTAP 2012

Tips and Tricks for Successful TAVR

Presenter: Gerald Yong

April 25, 2012

Presentation TCTAP 2012

Plaque Progression and Instability: Critical Insights from Pathology

Presenter: Renu Virmani

April 25, 2012

Presentation TCTAP 2012

Complications in TAVI

Presenter: Bernard Chevalier

April 25, 2012

Presentation TCTAP 2012

When is TAVR Not Cost-Effective?

Presenter: David J. Cohen

April 25, 2012

Presentation TCTAP 2012

What’s the Benchmark: Is there a Gold Standard for SFA Revascularization?

Presenter: Lawrence A. Garcia

April 25, 2012

Presentation TCTAP 2012

Valve-in-valve TAVI Implantation

Presenter: Eberhard Grube

April 25, 2012

Presentation TCTAP 2012

Transcatheter Aortic Valve Implantation - Stroke: Etiology and Prevention

Presenter: Corrado Tamburino

April 25, 2012

Presentation TCTAP 2012

TAVI for Patients with Complex Valvular Disease: The Bicuspid Aortic Valve

Presenter: B. Chevalier

April 25, 2012

Presentation TCTAP 2012

Drug-Eluting Balloon or Stent In Femoropopliteal Lesions: How Far Are We?

Presenter: Mark W. Burket

April 25, 2012

Presentation TCTAP 2012

ACTIVE Study with CoCr Balloon Expandable Stent What advantages over Standard Self-Expandable Stent?

Presenter: William A. Gray

April 25, 2012

Conference TCTAP 2012

TCT Asia-Pacific 2012

April 25, 2012

April 26, 2012

Conference TCTAP 2013

TCTAP 2013

April 24, 2013

Advertisement

From ABSORB Cohort A to ABSORB III and IV Randomized Trials

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Everolimus-Eluting Stent Implantation for Unprotected Left Main Stenosis:

Drug-Eluting Stent In Lower Extremity Intervention: Changed Landscape in the Current Practice?

CROSS and PERFECT Trials: Preliminary Results

ACCEL-LOADING-ACS: Multicenter Randomized Trial Evaluating Efficacy of Cilostazol on Platelet aggregation, Inflammation, and Myonecrosis in ACS Patients

Tips and Tricks for Successful TAVR

Plaque Progression and Instability: Critical Insights from Pathology

Complications in TAVI

When is TAVR Not Cost-Effective?

What’s the Benchmark: Is there a Gold Standard for SFA Revascularization?

Valve-in-valve TAVI Implantation

Transcatheter Aortic Valve Implantation - Stroke: Etiology and Prevention

TAVI for Patients with Complex Valvular Disease: The Bicuspid Aortic Valve

Drug-Eluting Balloon or Stent In Femoropopliteal Lesions: How Far Are We?

ACTIVE Study with CoCr Balloon Expandable Stent What advantages over Standard Self-Expandable Stent?

TCT Asia-Pacific 2012

TCTAP 2013

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content